Satish Eraly

Senior Medical Director at Alnylam Pharmaceuticals

Speaker

Satish holds MD, PhD in Neuroscience & Molecular Biology, and Masters in Clinical Research & Statistics degrees from UCSD. Following completion of scientific and clinical training, Satish served on the faculty at UCSD for over a decade, before joining industry. He was at Biogen for 7 years, working on the development of multiple drugs for ALS and MS (across modalities, including antisense oligonucleotides), before joining Alnylam, where for the last 3 years he has worked on the clinical development of RNAi therapeutics, including vutrisiran, a compound approved this year for the treatment of the cardiomyopathy of ATTR.